text_1: Ginger Supplements Might Ease Inflammation Linked to Colon Cancer
text_2: The goal of the study was to show that the colon lining had decreased levels of inflammatory markers. Although this was accomplished in this very small and short study, it remains unclear whether this has any importance in the complex pathways that lead to colonic polyps and ultimately, malignancies. Look at how the headline – which starts the story – and the final sentence – conflict:  HEADLINE:  Ginger Supplements Might Ease Inflammation Linked to Colon Cancer FINAL SENTENCE: “It’s much too early to tell whether ginger has anti-cancer properties.”   Americans are overwhelmed by a tsunami of health care news every day. Why was it vital that they receive this extremely preliminary information now? Can the flood of health care news – including from such tiny, early studies – simply confuse and turn off readers? We think so. News decision-makers may say “Our readers have an unsatiable appetite for health news.”  But where is the evidence that they want this kind of medical minutiae? Reporting on results with